FDA Approves Zydelig To Treat Pateints With Three Types of Blood Cancers

July 24, 2014 7:40 AM

35 0

The U.S. Food and Drug Administration approved Zydelig to treat patients with three types of blood cancers.

In a latest announcement, the FDA approved Gilead Sciences' Zydelig to treat patients whose chronic lymphocytic leukemia (CLL) has returned. The drug is to be used in combination with Rituxan to treat those for whom Rituxan alone was not an appropriate therapy due to other existing medical condition...

Read more

To category page